Teradyne (TER) Cost of Revenue (2009 - 2026)

Teradyne has disclosed Cost of Revenue across 18 years of filings, most recently posting $501.5 million for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 85.52% year-over-year to $501.5 million in Q1 2026; TTM through Mar 2026 was $1.6 billion, a 32.45% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 13.81% from the prior year.
• Cost of Revenue came in at $501.5 million for Q1 2026 at Teradyne, up from $463.6 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $501.5 million in Q1 2026 and troughed at $260.5 million in Q1 2024.
• Historically, Cost of Revenue has averaged $319.6 million across 5 years, with a median of $304.0 million in 2024.
• Year-over-year, Cost of Revenue declined 23.79% in 2022 and soared 85.52% in 2026.
• Teradyne's Cost of Revenue stood at $311.4 million in 2022, then slipped by 6.53% to $291.1 million in 2023, then increased by 5.0% to $305.6 million in 2024, then jumped by 51.72% to $463.6 million in 2025, then advanced by 8.17% to $501.5 million in 2026.
• The last three Cost of Revenue figures came in at $501.5 million (Q1 2026), $463.6 million (Q4 2025), and $319.9 million (Q3 2025), per Business Quant data.